R. Bert Wilkins, JD, MHA, CIP
Regulatory Chair Director, WCG
Biography
R. Bert Wilkins is one of the Regulatory Chair Directors WCG Institutional Review Board (WCG IRB). Bert has been working for IRBs since 2007. In this role, Bert advises the IRB on appropriateness and regulatory aspects of a wide array of research such as FDA regulated studies, Social/Behavioral Health research, International research, Emergency Research, and research involving vulnerable subjects.
Bert earned a BS from University of Washington, a MHA from University of North Carolina at Chapel Hill, and then a JD from Seattle University.
Latest insights by R. Bert
WCG Clinical | Insights
Answering FAQs on HIPAA & PHI: Protect Participants’ Privacy & Ensure Compliance
Blog Posts
WCG Clinical | Insights
Review of Emergency Research
Whitepapers
WCG Clinical | Insights
A Review Of The Regulatory Landscape for In Vitro Gametogenesis
Blog Posts
WCG Clinical | Insights
Function over Form: Assessing Different Consent Form Formats
Whitepapers
WCG Clinical | Insights
Should Parents Be Allowed to View their Child’s Survey Responses?
Blog Posts
WCG Clinical | Insights
Ethical and Regulatory Considerations in Patient-to-Patient-Referral Recruitment Plans
Whitepapers
WCG Clinical | Insights
Do You Know Me?: The Subtle Distinction Between “Anonymous” and “De-identified” Data in Clinical Research
Whitepapers
WCG Clinical | Insights